International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics  Marek Jutel, MD, Ioana Agache, MD, Sergio Bonini,

Slides:



Advertisements
Similar presentations
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and.
Advertisements

Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Allergen immunotherapy: A practice parameter third update
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2  Natalija Novak, MD, Nihal Mete, MD, Caroline.
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.
Innate microbial sensors and their relevance to allergy
OX40/OX40 Ligand Interactions in T-Cell Regulation and Asthma
Regulatory T cells in allergic diseases
Basophils and allergic inflammation
Proximal signaling events in FcɛRI-mediated mast cell activation
Advances in food allergy in 2015
Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance  Margot Berings, MD, Cagatay Karaaslan,
IL-17–producing T cells in lung immunity and inflammation
Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis  Julia K. Gittler, BA, James G. Krueger,
Dendritic cells: Bridging innate and adaptive immunity in atopic dermatitis  Natalija Novak, MD, Susanne Koch, PhD, Jean-Pierre Allam, MD, Thomas Bieber,
Therapeutic pipeline for atopic dermatitis: End of the drought?
Jennifer L. Ingram, PhD, Monica Kraft, MD 
Biologic Therapy and Novel Molecular Targets of Severe Asthma
Is 9 more than 2 also in allergic airway inflammation?
Thomas F. Tedder, PhD, Takashi Matsushita, MD, PhD 
International consensus on allergy immunotherapy
Histamine in the immune regulation of allergic inflammation
The enigma of IgE+ B-cell memory in human subjects
Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11  Luciana Kase Tanno, MD, PhD,
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and.
Update on Immune Mechanisms Associated with Sublingual Immunotherapy: Practical Implications for the Clinician  Philippe Moingeon, PhD  The Journal of.
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.
Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent  Brittany M. Salter, BSc, John Paul Oliveria,
The 3 major types of innate and adaptive cell-mediated effector immunity  Francesco Annunziato, PhD, Chiara Romagnani, MD, PhD, Sergio Romagnani, MD  Journal.
Mucosal Immunology of Food Allergy
TH17 and TH22 cells: A confusion of antimicrobial response with tissue inflammation versus protection  Mübeccel Akdis, MD, PhD, Oscar Palomares, PhD,
Innate lymphoid cells in allergic and nonallergic inflammation
OX40/OX40 Ligand Interactions in T-Cell Regulation and Asthma
Epithelium: At the interface of innate and adaptive immune responses
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases  Mübeccel Akdis, MD, PhD, Simone Burgler, PhD, Reto Crameri,
Current and Future Treatment of Peanut Allergy
Human innate lymphoid cells
Immunology of Food Allergy
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
B-lymphocyte lineage cells and the respiratory system
Can we produce true tolerance in patients with food allergy?
Biosimilars and drug development in allergic and immunologic diseases
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis—or should we really say mastocytic esophagitis?  J. Pablo Abonia, MD, James P. Franciosi,
The role of the T cell in asthma
The IgE memory reservoir in food allergy
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Asthma and Allergic Inflammation
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Mohamed H. Shamji, PhD, FAAAI, Stephen R. Durham, MD, FRCP 
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy  Fatimah Kussebi, MD, Fariba Karamloo, PhD, Claudio Rhyner,
Bart N. Lambrecht, MD, PhD, Hamida Hammad, PhD 
Chemokines and their receptors in allergic disease
Mechanisms of food allergy
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness  Michael R. Edwards, PhD, Katherine Strong,
Mechanisms of immune tolerance relevant to food allergy
Molecular and cellular mechanisms of allergic disease
Does “autoreactivity” play a role in atopic dermatitis?
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity  James N. Francis, PhD, Louisa.
Innate lymphoid cells in allergic and nonallergic inflammation
TH2 adjuvants: Implications for food allergy
Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy.
Leonie Hussaarts, MSc, Luciën E. P. M
Molecular and cellular mechanisms of food allergy and food tolerance
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts  Emma Guttman-Yassky, MD, PhD, Kristine.
Advances and highlights in mechanisms of allergic disease in 2015
The future of biologics: Applications for food allergy
Presentation transcript:

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics  Marek Jutel, MD, Ioana Agache, MD, Sergio Bonini, MD, A. Wesley Burks, MD, Moises Calderon, MD, Walter Canonica, MD, Linda Cox, MD, Pascal Demoly, MD, Antony J. Frew, MD, FRCP, Robyn O'Hehir, FRACP, PhD, Jörg Kleine-Tebbe, MD, Antonella Muraro, MD, PhD, Gideon Lack, MD, Désirée Larenas, MD, Michael Levin, MD, Bryan L. Martin, MD, Harald Nelson, MD, Ruby Pawankar, MD, Oliver Pfaar, MD, Ronald van Ree, PhD, Hugh Sampson, MD, James L. Sublett, MD, Kazunari Sugita, MD, George Du Toit, MD, Thomas Werfel, MD, Roy Gerth van Wijk, MD, Luo Zhang, MD, Mübeccel Akdis, MD, Cezmi A. Akdis, MD  Journal of Allergy and Clinical Immunology  Volume 137, Issue 2, Pages 358-368 (February 2016) DOI: 10.1016/j.jaci.2015.12.1300 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Cellular and molecular changes during AIT. A, Differentiation of naive T cells after allergen presentation in the presence of innate immune response substances that trigger pattern recognition receptors (PRR) and vitamins, monoamines that control cellular differentiation, and coexposed substances with the antigen and status of the cells and cytokines in the microenvironment is shown. Naive T cells can differentiate into TH1, TH2, TH9, TH17, and TH22 T cells. Based on their respective cytokine profiles, responses to chemokines, and interactions with other cells, these T-cell subsets can contribute to general inflammation. The increase in TH1 and Treg cell numbers plays a role in counterbalancing other effector cells. The balance between allergen-specific effector T cells (particularly TH2 cells) and IL-10–producing Treg cells is decisive for the development or suppression of allergic inflammation. Treg cells and their cytokines suppress TH2-type immune responses and contribute to the control of allergic diseases in several major ways. Similarly, induction of IL-10–producing Breg cells plays an essential role in suppression of IgE and induction of IgG4. B, The suppression of peripheral ILCs, especially ILC2s, might contribute to TH2 suppression and immunologic tolerance induced by AIT. iNKT, Invariant natural killer T; TSLP, thymic stromal lymphopoietin. Journal of Allergy and Clinical Immunology 2016 137, 358-368DOI: (10.1016/j.jaci.2015.12.1300) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Cellular and molecular changes during AIT. A, Differentiation of naive T cells after allergen presentation in the presence of innate immune response substances that trigger pattern recognition receptors (PRR) and vitamins, monoamines that control cellular differentiation, and coexposed substances with the antigen and status of the cells and cytokines in the microenvironment is shown. Naive T cells can differentiate into TH1, TH2, TH9, TH17, and TH22 T cells. Based on their respective cytokine profiles, responses to chemokines, and interactions with other cells, these T-cell subsets can contribute to general inflammation. The increase in TH1 and Treg cell numbers plays a role in counterbalancing other effector cells. The balance between allergen-specific effector T cells (particularly TH2 cells) and IL-10–producing Treg cells is decisive for the development or suppression of allergic inflammation. Treg cells and their cytokines suppress TH2-type immune responses and contribute to the control of allergic diseases in several major ways. Similarly, induction of IL-10–producing Breg cells plays an essential role in suppression of IgE and induction of IgG4. B, The suppression of peripheral ILCs, especially ILC2s, might contribute to TH2 suppression and immunologic tolerance induced by AIT. iNKT, Invariant natural killer T; TSLP, thymic stromal lymphopoietin. Journal of Allergy and Clinical Immunology 2016 137, 358-368DOI: (10.1016/j.jaci.2015.12.1300) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Rapid desensitization. Very early decreases in the susceptibility of mast cells and basophils to degranulation are observed. Mediators of anaphylaxis (histamine and leukotrienes) are released during AIT without inducing a systemic anaphylactic response. Several mechanisms have been proposed, such as upregulation of histamine type 2 receptors and decreased effector cell function, as reflected by a decrease in allergen-stimulated surface expression of CD63. Early changes in basophil sensitivity predict symptom relief with AIT. Immune tolerance involves the gradual increase in Treg and Breg cell numbers and tolerogenic antibody levels. Long-term tolerance induced by AIT involves changes in the memory T- and B-cell compartment, the TH1/TH2 shift, and the function of effector and structural cells. Journal of Allergy and Clinical Immunology 2016 137, 358-368DOI: (10.1016/j.jaci.2015.12.1300) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions